Cannabis Real Estate Insights — May 2026

Commercial Division | May 2026

A monthly briefing for Michigan cannabis entrepreneurs, operators, and lenders.

Cannabis Industry Pulse

Federal Cannabis Rescheduling: DEA Moves State-Licensed Medical Marijuana to Schedule III

On April 23, 2026, the DEA issued its Final Order reclassifying state-licensed medical marijuana from Schedule I to Schedule III under the Controlled Substances Act. The order implements President Trump's December 2025 Executive Order and opens an expedited federal licensing pathway. For cannabis real estate, this changes lender risk tolerance, title insurance underwriting posture, and any lease provisions tied to federal illegality. Recreational cannabis is not federally legal — but the landscape for medical cannabis property transactions has fundamentally changed.

Source: Michigan LARA / DEA Final Order — April 23, 2026

Michigan Cannabis Market Under Pressure: Prices Down 8%, Wholesale Tax Bites

The average ounce of cannabis flower at Michigan adult-use dispensaries fell to $59.85 in February 2026, down 8.2% year-over-year. January recreational sales dropped 16% month-over-month to $226 million. The new 24% wholesale tax, effective January 1, is compressing margins in an oversupplied market with 956 cultivation licensees, 275 processors, and 835 dispensaries. The pricing pressure is accelerating facility turnover — creating both acquisition opportunities and title complications for buyers inheriting complex license-tied assets.

Source: Cannabis Business Times — Michigan Market Update, February 2026

Michigan Regulatory Watch

Cannabis Regulatory Agency (CRA) updates affecting real estate.

The Michigan Cannabis Regulatory Agency (CRA) released its March 2026 Disciplinary Action Report covering enforcement actions against adult-use and medical licensees statewide. The CRA also issued a press release acknowledging the DEA's April 23 federal rescheduling order and confirmed it is analyzing the order's impact on Michigan operations, policies, and compliance obligations.

No changes to state licensing or zoning requirements have been announced yet, but operators and property owners should monitor for updated guidance. Michigan remains a local-opt-in state regardless of what happens at the federal level.

Transaction Spotlight

Details anonymized to protect client confidentiality.

Property Type: Former cannabis cultivation facility (indoor grow operation) Transaction: Sale on land contract to a non-cannabis end user

This closing reflects a pattern we are seeing as Michigan's cannabis market consolidates: cannabis-zoned properties changing hands to buyers who have no intention of operating a cannabis business. When a former grow facility sells on a land contract, the title work gets more complicated, not less — and the land contract structure was the central complication here.

Land contracts create a split interest — the vendor retains legal title while the vendee holds equitable title and possession. That split raises specific questions: how does the commitment reflect the vendor's retained interest, and how is the vendee's equitable interest insured under the same policy? We structured Schedule B exceptions and endorsements that tracked the land contract terms so the coverage matched the deal as written.

The deal closed cleanly because the title work anticipated how a split interest interacts with a cannabis-zoned parcel. Expect more conversion transactions on land contract terms as operators exit the market — each requires a title agent who knows how to write a commitment that protects both vendor and vendee through the life of the contract.

From Dave's Desk

May brought the biggest federal cannabis policy shift in decades — the DEA's rescheduling of state-licensed medical marijuana to Schedule III. My phone has been ringing with questions from operators, lenders, and attorneys asking what it means for their Michigan deals.

The short answer: it changes the federal risk calculus but not the state mechanics. What it does change is the conversation with lenders and underwriters about risk — a conversation I've been having for years.

Looking forward to the MLTA convention this July at Boyne Mountain — if you're attending, let's connect.

— Dave Nykanen

Work With Us

If you're acquiring, financing, or developing cannabis-zoned property in Michigan, we handle the title complexities that general agents won't touch. Reach out for a conversation about your next transaction.

📧 commercial@mwtmi.com

Stay Connected

Follow us on LinkedIn: Midwest Title Commercial | Dave Nykanen

About Midwest Title and Dave Nykanen

Midwest Title's Commercial Division handles Michigan's most complex commercial closings — including cannabis-zoned acquisitions, license-tied property transfers, multi-parcel operator consolidations, and the buffer-zone, zoning, and underwriting issues that scare off generalist title agents. Founded and led by Dave Nykanen, a licensed Michigan real estate attorney with three decades of experience in commercial real estate as both a practicing attorney and a title agent, the division brings legal and underwriting depth that cannabis transactions demand.

commercial@mwtmi.com | Midwest Title Commercial Division | Michigan-Licensed Title Insurance Agent

This newsletter is for informational purposes only and does not constitute legal advice.

Previous
Previous

Commercial Insights For the Title Industry - May 2026